Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients
11 mars 2024 08h05 HE
|
Allyx Therapeutics Inc.
Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients
PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
08 mars 2024 16h15 HE
|
PharmAla Biotech
PharmAla provides corporate update following AGM
Pediatric Clinical Trials Market Poised for Growth Amid Innovative Treatments and Advanced Research Technologies
08 mars 2024 09h26 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global pediatric clinical...
Clinical Trial Supply and Logistics Market Sees Promising Growth as Demand for Personalized Medicine Surges
07 mars 2024 12h04 HE
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply and Logistics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global clinical...
Preclinical Assets Market to Surge, Spotlight on Advances in Asia-Pacific
07 mars 2024 12h03 HE
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Assets Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global preclinical assets market has...
Non-Animal Alternatives Testing Global Market Report 2024
06 mars 2024 04h04 HE
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Non-Animal Alternatives Testing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The non-animal alternatives...
H1 Recognized as One of Forbes’ Best Startup Employers in 2024
05 mars 2024 10h32 HE
|
H1
NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global healthcare professionals, clinical trial, and research information for life sciences, today announced that it...
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
04 mars 2024 08h00 HE
|
Quoin Pharmaceuticals, Inc.
Clearance to include teen patients in both the company’s open label and placebo controlled studies expected to significantly expand the number of eligible subjects, potentially expedite recruitment...
Malaria Global Clinical Trials Review 2024, Featuring GSK, Sanaria, Novartis, Nucleus Network, Sanofi Shin Poong Pharm, Pfizer, Sun Pharmaceutical, IPCA Laboratories and Richmond Pharmacology
01 mars 2024 04h27 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Malaria - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides...
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond
29 févr. 2024 04h06 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...